Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Indications/Uses

Control and Prevention of Bleeding Episodes in Hemophilia A: XYNTHA, Antihemophilic Factor (Recombinant), Plasma/Albumin-Free, is indicated for the control and prevention of bleeding episodes, as well as routine prophylaxis to reduce bleeding episodes, in patients with hemophilia A (congenital factor VIII deficiency or classic hemophilia).
XYNTHA does not contain von Willebrand factor, and therefore is not indicated in patients with von Willebrand's disease.
Surgical Prophylaxis in Patients with Hemophilia A: XYNTHA, Antihemophilic Factor (Recombinant), Plasma/Albumin-Free, is indicated for surgical prophylaxis in patients with hemophilia A.
Pediatric Use: XYNTHA is appropriate for use in children of all ages, including newborns.

Xyntha Indications/Uses

factor viii

Manufacturer:

Pfizer

Distributor:

Zuellig Pharma